Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: 22q11 DiGeorge Syndrome is primarily diagnosed through specialized genetic testing, specifically a chromosomal microarray (CMA) or fluorescence in situ hybridization (FISH) to detect a deletion on chromosome 22. Because the condition presents with a wide spectrum of symptoms—ranging from cardiac defects to immune deficiencies—it is often identified by a multidisciplinary team of specialists following the clinical suspicion of systemic physical or developmental differences. How is 22q11 DiGeorge Syndrome clinically diagnosed? The diagnostic journey for 22q11 DiGeorge Syndrome often begins when a physician notices a pattern of clinical features, such as distinct facial characteristics, heart defects, or recurrent infections.
2 people with 22q11 DiGeorge Syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: 22q11 DiGeorge Syndrome is primarily diagnosed through specialized genetic testing, specifically a chromosomal microarray (CMA) or fluorescence in situ hybridization (FISH) to detect a deletion on chromosome 22. Because the condition presents with a wide spectrum of symptoms—ranging from cardiac defects to immune deficiencies—it is often identified by a multidisciplinary team of specialists following the clinical suspicion of systemic physical or developmental differences.
The diagnostic journey for 22q11 DiGeorge Syndrome often begins when a physician notices a pattern of clinical features, such as distinct facial characteristics, heart defects, or recurrent infections. Because the phenotype is so variable, there is no single "look" for the syndrome. Clinicians typically look for a combination of the "CATCH-22" features: Cardiac defects, Abnormal facies, Thymic hypoplasia, Cleft palate, and Hypocalcemia. When these are observed, a referral to a clinical geneticist is the gold standard for confirming a diagnosis of 22q11 DiGeorge Syndrome.
Confirmation of 22q11 DiGeorge Syndrome requires molecular genetic testing to identify the microdeletion on the long arm of chromosome 22. The following tests are commonly utilized in the diagnostic process:
For many of the 215 members in our DiseaseMaps community, the "diagnostic odyssey" is a source of profound frustration. Because 22q11 DiGeorge Syndrome can mimic other conditions like autism spectrum disorder, developmental delay, or isolated congenital heart disease, families often spend years visiting various specialists before a genetic cause is identified. It is normal to feel exhausted by this process; please know that your search for answers is valid. If your primary care provider is unfamiliar with the syndrome, do not hesitate to request a referral to a clinical geneticist or a center specializing in rare pediatric conditions.
Diagnosing 22q11 DiGeorge Syndrome is a team effort. You will likely interact with a clinical geneticist, who coordinates the testing, as well as pediatric cardiologists, immunologists, and endocrinologists. Because the condition is multisystemic, differential diagnosis is vital to rule out other syndromes with overlapping features, such as CHARGE syndrome or VACTERL association. Working with a coordinated team ensures that no symptom is overlooked and that your care is managed holistically.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.